The presence of a pituitary adenoma, confirmed by MRI, raises the possibility that gonadotropin receptor function was altered by the lesion—an aberration that became clinically evident only after repeated GnRH agonist administration. This evidence concerns the gene LGR6 and pituitary gland adenoma.